{"pmid":32324101,"title":"Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands.","text":["Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands.","A potential link between mortality, D-dimer values and a prothrombotic syndrome has been reported in patients with COVID-19 infection. The National Institute for Public Health of the Netherlands asked a group of Radiology and Vascular Medicine experts to provide guidance for the imaging workup and treatment of these important complications. This report summarizes evidence for thromboembolic disease, potential diagnostic and preventive actions as well as recommendations for patients with COVID-19 infection.","Radiology","Oudkerk, Matthijs","Buller, Harry R","Kuijpers, Dirkjan","van Es, Nick","Oudkerk, Sitse F","McLoud, Theresa C","Gommers, Diederik","van Dissel, Jaap","Ten Cate, Hugo","van Beek, Edwin J","32324101"],"abstract":["A potential link between mortality, D-dimer values and a prothrombotic syndrome has been reported in patients with COVID-19 infection. The National Institute for Public Health of the Netherlands asked a group of Radiology and Vascular Medicine experts to provide guidance for the imaging workup and treatment of these important complications. This report summarizes evidence for thromboembolic disease, potential diagnostic and preventive actions as well as recommendations for patients with COVID-19 infection."],"journal":"Radiology","authors":["Oudkerk, Matthijs","Buller, Harry R","Kuijpers, Dirkjan","van Es, Nick","Oudkerk, Sitse F","McLoud, Theresa C","Gommers, Diederik","van Dissel, Jaap","Ten Cate, Hugo","van Beek, Edwin J"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32324101","week":"202017|Apr 20 - Apr 26","doi":"10.1148/radiol.2020201629","source":"PubMed","topics":["Treatment","Diagnosis"],"weight":1,"_version_":1664895932758491138,"score":8.518259,"similar":[{"pmid":32305585,"title":"Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 Pandemic.","text":["Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 Pandemic.","A markedly increased demand for vascular ultrasound laboratory and other imaging studies in COVID-19 positive patients has occurred, due to most with markedly elevated D-dimer, and a presumed prothrombotic state in many of the very ill patients. This article summarizes a broad institutional consensus focusing on evaluation and recommended empirical therapy for COVID-19 positive patients. We recommend following the algorithms with the idea that as more data becomes available that this may well change.","J Vasc Surg Venous Lymphat Disord","Obi, Andrea T","Barnes, Geoff D","Wakefield, Thomas W","Brown Rvt, Sandra","Eliason, Jonathon L","Arndt, Erika","Henke, Peter K","32305585"],"abstract":["A markedly increased demand for vascular ultrasound laboratory and other imaging studies in COVID-19 positive patients has occurred, due to most with markedly elevated D-dimer, and a presumed prothrombotic state in many of the very ill patients. This article summarizes a broad institutional consensus focusing on evaluation and recommended empirical therapy for COVID-19 positive patients. We recommend following the algorithms with the idea that as more data becomes available that this may well change."],"journal":"J Vasc Surg Venous Lymphat Disord","authors":["Obi, Andrea T","Barnes, Geoff D","Wakefield, Thomas W","Brown Rvt, Sandra","Eliason, Jonathon L","Arndt, Erika","Henke, Peter K"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305585","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jvsv.2020.04.009","keywords":["anticoagulant","deep venous thrombosis","duplex ultrasound","pulmonary embolism","venous thromboembolism"],"source":"PubMed","topics":["Treatment","Diagnosis"],"weight":1,"_version_":1664641855752503296,"score":273.89386},{"pmid":32304577,"title":"Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidence and call for action.","text":["Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidence and call for action.","Emerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated with coagulopathy namely disseminated intravascular coagulation, which has a rather pro-thrombotic character with high risk of venous thromboembolism. The incidence of venous thromboembolism among COVID-19 patients in Intensive Care Unit appears to be somewhat higher compared to that reported in other studies including such patients with other disease conditions. D-dimer might help in early recognition of these high-risk patients and also predict outcome. Preliminary data show that in patients with severe COVID-19, anticoagulant therapy appears to be associated with lower mortality in the subpopulation meeting sepsis-induced coagulopathy criteria or with markedly elevated d-dimer. Recent recommendations suggest that all hospitalized COVID-19 patients should receive thromboprophylaxis, or full therapeutic-intensity anticoagulation if such an indication is present.","Br J Haematol","Kollias, Anastasios","Kyriakoulis, Konstantinos G","Dimakakos, Evangelos","Poulakou, Garyphallia","Stergiou, George S","Syrigos, Konstantinos","32304577"],"abstract":["Emerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated with coagulopathy namely disseminated intravascular coagulation, which has a rather pro-thrombotic character with high risk of venous thromboembolism. The incidence of venous thromboembolism among COVID-19 patients in Intensive Care Unit appears to be somewhat higher compared to that reported in other studies including such patients with other disease conditions. D-dimer might help in early recognition of these high-risk patients and also predict outcome. Preliminary data show that in patients with severe COVID-19, anticoagulant therapy appears to be associated with lower mortality in the subpopulation meeting sepsis-induced coagulopathy criteria or with markedly elevated d-dimer. Recent recommendations suggest that all hospitalized COVID-19 patients should receive thromboprophylaxis, or full therapeutic-intensity anticoagulation if such an indication is present."],"journal":"Br J Haematol","authors":["Kollias, Anastasios","Kyriakoulis, Konstantinos G","Dimakakos, Evangelos","Poulakou, Garyphallia","Stergiou, George S","Syrigos, Konstantinos"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32304577","week":"202016|Apr 13 - Apr 19","doi":"10.1111/bjh.16727","keywords":["sars-cov-2","anticoagulant","prophylaxis","thromboembolism","thrombosis"],"source":"PubMed","topics":["Treatment","Prevention"],"weight":1,"locations":["thromboprophylaxis"],"_version_":1664632934588481537,"score":168.44365},{"pmid":32316065,"title":"Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.","text":["Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.","Coronavirus disease 2019 (COVID-19) has caused a global pandemic in just a few months, causing millions infected. Nearly 20% of COVID-19 patients present severe coagulation abnormalities, which may occur in almost all of the severe and critical ill COVID-19 cases. Concomitant venous thromboembolism (VTE), a potential cause of unexplained deaths, has been frequently reported in COVID-19 cases, but its management is still challenging due to the complexity between antithrombotic therapy and coagulation disorders. Based on frontline practical experience and comprehensive literature review, here a panel of experts and physicians from China and Europe developed an evidence and opinion-based consensus on the prophylaxis and management of VTE associated with COVID-19. This statement aims for clinicians treating COVID-19 and provides practical recommendations in detailed situations, for example, how to choose thromboprophylactic measures for patients with diverse severity of disease and bleeding risk, or which kind of anticoagulant should be prescribed. With limited experience on COVID19-associated VTE, this expert consensus statement should be helpful for clinicians worldwide with specific suggestions.","Thromb Haemost","Zhai, Zhenguo","Li, Chenghong","Chen, Yaolong","Gerotziafas, Grigorios","Zhang, Zhenlu","Wan, Jun","Liu, Peng","Elalamy, Ismail","Wang, Chen","32316065"],"abstract":["Coronavirus disease 2019 (COVID-19) has caused a global pandemic in just a few months, causing millions infected. Nearly 20% of COVID-19 patients present severe coagulation abnormalities, which may occur in almost all of the severe and critical ill COVID-19 cases. Concomitant venous thromboembolism (VTE), a potential cause of unexplained deaths, has been frequently reported in COVID-19 cases, but its management is still challenging due to the complexity between antithrombotic therapy and coagulation disorders. Based on frontline practical experience and comprehensive literature review, here a panel of experts and physicians from China and Europe developed an evidence and opinion-based consensus on the prophylaxis and management of VTE associated with COVID-19. This statement aims for clinicians treating COVID-19 and provides practical recommendations in detailed situations, for example, how to choose thromboprophylactic measures for patients with diverse severity of disease and bleeding risk, or which kind of anticoagulant should be prescribed. With limited experience on COVID19-associated VTE, this expert consensus statement should be helpful for clinicians worldwide with specific suggestions."],"journal":"Thromb Haemost","authors":["Zhai, Zhenguo","Li, Chenghong","Chen, Yaolong","Gerotziafas, Grigorios","Zhang, Zhenlu","Wan, Jun","Liu, Peng","Elalamy, Ismail","Wang, Chen"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32316065","week":"202017|Apr 20 - Apr 26","doi":"10.1055/s-0040-1710019","source":"PubMed","topics":["Treatment"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664714520045551617,"score":148.95482},{"pmid":32324960,"title":"Laboratory haemostasis monitoring in COVID-19.","text":["Laboratory haemostasis monitoring in COVID-19.","We thank the authors for their very useful and constructive criticisms about laboratory monitoring of haemostatic variables detailed in the ISTH guidance document for coagulopathy in COVID-19. We still believe that the use of simple and easily available laboratory markers both at admission and whilst in the hospital is necessary in the management of COVID-19 patients. Since the writing of this guidance and the letter from the experts being sent to us, there have been several reports of very high incidence of both arterial and venous thromboembolism (TE) in patients with COVID-19.(1,2,3) In one report published in the Journal of Thrombosis and Haemostasis, the incidence of venous TE was 25%, some of whom died from this complication.(2) Laboratory markers including D-dimer were relevant in these patients. The authors used D-dimer cut-off of 1.5 microg/mL for predicting venous TE and demonstrated sensitivity of 85.0% and specificity of 88.5% and negative predictive value of 94.7%.(2) They also suggested D-dimers may be used to monitor the effectiveness of anticoagulants although this practice is not universally accepted.","J Thromb Haemost","Thachil, Jecko","Tang, Ning","Gando, Satoshi","Falanga, Anna","Levi, Marcel","Clark, Cary","Iba, Toshiaki","32324960"],"abstract":["We thank the authors for their very useful and constructive criticisms about laboratory monitoring of haemostatic variables detailed in the ISTH guidance document for coagulopathy in COVID-19. We still believe that the use of simple and easily available laboratory markers both at admission and whilst in the hospital is necessary in the management of COVID-19 patients. Since the writing of this guidance and the letter from the experts being sent to us, there have been several reports of very high incidence of both arterial and venous thromboembolism (TE) in patients with COVID-19.(1,2,3) In one report published in the Journal of Thrombosis and Haemostasis, the incidence of venous TE was 25%, some of whom died from this complication.(2) Laboratory markers including D-dimer were relevant in these patients. The authors used D-dimer cut-off of 1.5 microg/mL for predicting venous TE and demonstrated sensitivity of 85.0% and specificity of 88.5% and negative predictive value of 94.7%.(2) They also suggested D-dimers may be used to monitor the effectiveness of anticoagulants although this practice is not universally accepted."],"journal":"J Thromb Haemost","authors":["Thachil, Jecko","Tang, Ning","Gando, Satoshi","Falanga, Anna","Levi, Marcel","Clark, Cary","Iba, Toshiaki"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32324960","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jth.14866","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664895932790996992,"score":142.22849},{"pmid":32271988,"title":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.","text":["Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.","BACKGROUND: Since 3 months ago, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) broke out in Wuhan, China, and spread rapidly around the world. Severe novel coronavirus pneumonia (NCP) patients have abnormal blood coagulation function, but their venous thromboembolism(VTE) prevalence is still rarely mentioned. OBJECTIVES: To determine the incidence of VTE in patients with severe NCP. METHODS: In this study, 81 severe NCP patients in the Intensive Care Unit (ICU) of Union Hospital (Wuhan, China) were enrolled. The results of conventional coagulation parameters and lower limb vein ultrasonography of these patients were retrospectively collected and analyzed. RESULTS: The incidence of VTE in these patients was 25%(20/81), of which 8 patients with VTE events died. VTE group was different from non-VTE group in age, lymphocytes counts, activated partial thromboplastin time (APTT), D-dimer, etc. If 1.5 microg/mL was used as the D-dimer cut-off value to predicting VTE, the sensitivity was 85.0%, the specificity was 88.5% and the negative predictive value (NPV) was 94.7%. CONCLUSIONS: The incidence of VTE in patients with severe NCP is 25% (20/81), which may be related to poor prognosis. The significant increase of D-dimer in severe NCP patients is a good index for identifying high-risk groups of VTE.","J Thromb Haemost","Cui, Songping","Chen, Shuo","Li, Xiunan","Liu, Shi","Wang, Feng","32271988"],"abstract":["BACKGROUND: Since 3 months ago, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) broke out in Wuhan, China, and spread rapidly around the world. Severe novel coronavirus pneumonia (NCP) patients have abnormal blood coagulation function, but their venous thromboembolism(VTE) prevalence is still rarely mentioned. OBJECTIVES: To determine the incidence of VTE in patients with severe NCP. METHODS: In this study, 81 severe NCP patients in the Intensive Care Unit (ICU) of Union Hospital (Wuhan, China) were enrolled. The results of conventional coagulation parameters and lower limb vein ultrasonography of these patients were retrospectively collected and analyzed. RESULTS: The incidence of VTE in these patients was 25%(20/81), of which 8 patients with VTE events died. VTE group was different from non-VTE group in age, lymphocytes counts, activated partial thromboplastin time (APTT), D-dimer, etc. If 1.5 microg/mL was used as the D-dimer cut-off value to predicting VTE, the sensitivity was 85.0%, the specificity was 88.5% and the negative predictive value (NPV) was 94.7%. CONCLUSIONS: The incidence of VTE in patients with severe NCP is 25% (20/81), which may be related to poor prognosis. The significant increase of D-dimer in severe NCP patients is a good index for identifying high-risk groups of VTE."],"journal":"J Thromb Haemost","authors":["Cui, Songping","Chen, Shuo","Li, Xiunan","Liu, Shi","Wang, Feng"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271988","week":"202015|Apr 06 - Apr 12","doi":"10.1111/jth.14830","keywords":["d-dimer","blood coagulation","coagulation parameter","novel coronavirus pneumonia","venous thromboembolism"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Wuhan","China","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664637315678470144,"score":136.01399}]}